Panoraia Gourdoupi - 20 Jul 2022 Form 3 Insider Report for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN)

Role
Director
Signature
/s/ Panoraia Gourdoupi
Issuer symbol
ADN
Transactions as of
20 Jul 2022
Net transactions value
$0
Form type
3
Filing time
05 Aug 2022, 17:55:09 UTC
Next filing
06 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADN Common Stock 379,485 20 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADN Employee Stock Options (right to buy) 20 Jul 2022 Common Stock 175,000 $2.74 Direct F2, F3
holding ADN Employee Stock Options (right to buy) 20 Jul 2022 Common Stock 75,000 $7.40 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 175,000 restricted stock units ("RSUs") granted July 12, 2022, and 75,000 RSUs granted August 31, 2021, each representing a contingent right to receive common stock. Such RSUs were granted pursuant to Issuer's 2021 Equity Incentive Plan, dated February 4, 2021 (the "Plan"). RSUs are a common stock equivalent that may be settled solely by delivery of an equal number of shares of Issuer's common stock. They vest 25% on each anniversary of their grant date over four years.
F2 Employee stock options (right to buy) ("Options") granted pursuant to the Plan.
F3 Options vest 25% over four years on each anniversary of the grant date and will be fully vested as of July 12, 2026.
F4 Options vest 25% over four years on each anniversary of the grant date and will be fully vested as of August 31, 2025.